Back

National Association for Continuing Education

  • Calcitonin Gene-Related Peptide
  • Headache
  • Migraine Disorders
  • Prescription Drug Overuse

Modernizing Migraine Management: Moving Past Stagnant Treatment Patterns

Persistent disability and frequent headache recurrence remain common challenges in acute migraine management, even among patients using traditional triptans or calcitonin gene-related peptide therapies. Primary care clinicians, who are on the front lines of treating migraine, must be able to identify suboptimal response and modify treatment plans appropriately. One such strategy is the use of multimechanistic therapies that target distinct pathophysiologic pathways to enhance efficacy. In this CME/CE webcast, Dr Jessica Ailani details the neurobiology of acute migraine, clarifies the rationale for multi-targeted intervention, and provides actionable frameworks for individualized pharmacotherapy selection and sequencing. By the end of this activity, participants will be equipped to move beyond stagnant treatment patterns, prevent medication overuse, and rapidly restore patient function in the face of acute migraine.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Sep 30, 2026
  • Last day to claim credit
    Oct 1, 2027 12 months left